warn! Covid pneumonia infections – more deaths How to prevent it? Read on.

But the situation in various hospitals now, the covid bed is quite tight. need to manage the bed because the covid bed has been adjusted to be used to care for general patients during the outbreak of the pandemic. Many hospitals are starting to have to adjust common beds to receive more covid cases. The … Read more

“Covid-19” drug treatment criteria for patients At what level to give favipiravir?

issue”Covid-19” medical department Dr. Somsak Ankasil, Director-General of the Department of Medical Services, revealed that the drug treatment criteria for COVID-19 patients are in accordance with the guidelines for medical practice, diagnosis, care and prevention of infection in hospitals. Case of Coronavirus Disease 2019 or COVID-19 for Doctors and Public Health Personnel, Revised Edition, May … Read more

“Covids today” in Ubon Ratchathani, total 3,935 infected, 3,599 ATK, 8 deaths.

Today (26 Apr 65) Ubon Ratchathani Provincial Public Health Office report the number of casesCovid-19 provinceUbon Ratchathani As of April 26, 2022, 3,935 new cases were found, of which 336 were confirmed cases.ATK) 3,599 people. In this wave of outbreaks, there are 165,215 cumulative patients. 29,285 are undergoing treatment. pneumonia 413 coma, 33 required intubation … Read more

Favipiravir is effective in treating coronavirus Improve symptoms 79%

Favipiravir is effective in treating coronavirus  Improve symptoms 79%

Dr. Opas Karnkawinpong, MD. Director-General of the Department of Disease Control along with Dr. Manus Phothaphon, Deputy Director-General of the Department of Medical Services Announcement on the benefits of using the drug “Favipiravir” in the treatment of COVID-19 patients by Dr. Opas said start of covid-19 is an emerging disease There is no specific cure … Read more

latest research favipiravir Helping patients infected with covid, less symptoms, 79% better.

latest research  favipiravir  Helping patients infected with covid, less symptoms, 79% better.

The results showed that Patients in the program started on average at 1.7 days after symptom onset when assessed by NEWS over a 14-day treatment period. The favipiravir treatment group improved by 79%, compared to 32.3% in the control group. The favipiravir group improved significantly faster. by half Patients who received favipiravir showed improvement from … Read more